| Urinary Tract Infection |
1 |
1 |
| Prophylaxis |
0 |
0.99 |
| Clinical Guidelines |
0 |
0.98 |
| Antibiotics |
0 |
0.42 |
| Recurrent Urinary Tract Infection |
0 |
0.38 |
| Vagina |
0 |
0.38 |
| Atrophic Vaginitis |
0 |
0.33 |
| Breast Cancer |
0 |
0.23 |
| Skin and Soft Tissue Infection |
0 |
0.2 |
| Bacteria |
0 |
0.19 |
| Acupuncture |
0 |
0.09 |
| Adverse Effects |
0 |
0.09 |
| Bladder |
0 |
0.09 |
| Breast |
0 |
0.09 |
| Cancer |
0 |
0.09 |
| Complementary and Alternative Medicine |
0 |
0.09 |
| Contraception |
0 |
0.09 |
| Cystitis |
0 |
0.09 |
| Diaphragm |
0 |
0.09 |
| Epithelium |
0 |
0.09 |
| Escherichia coli |
0 |
0.09 |
| Estrogen |
0 |
0.09 |
| Hand |
0 |
0.09 |
| Health Care Reform |
0 |
0.09 |
| Intrauterine Device |
0 |
0.09 |
| Microbicides |
0 |
0.09 |
| Outpatient Clinic |
0 |
0.09 |
| Patient Safety |
0 |
0.09 |
| Vaginitis |
0 |
0.09 |